DECOY BIOSYSTEMS
Decoy Biosystems is a biotechnology company developing a novel and potentially best in class, multiple Toll-like receptor (TLR) agonist-based cancer immunotherapy. Decoy is dedicated to enhancing the expanding curative cancer immunology for patients with unresectable or metastatic solid tumors and lymphomas, which are responsible for approximately 90 percent of all cancer deaths.
DECOY BIOSYSTEMS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2013-08-14
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.decoybio.com
Total Employee:
1+
Status:
Active
Contact:
858-492-0485
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Google Cloud Sectigo SSL Sectigo Domain SSL
Similar Organizations
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Sojournix
Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.
Current Employees Featured
Founder
Investors List
TY BIO Investment
TY BIO Investment investment in Seed Round - Decoy Biosystems
Mountain Pacific Partners
Mountain Pacific Partners investment in Seed Round - Decoy Biosystems
Official Site Inspections
http://www.decoybio.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Decoy Biosystems"
Decoy Biosystems - Crunchbase Company Profile & Funding
Decoy Biosystems is a biotechnology company developing a novel and potentially best in class, multiple Toll-like receptor (TLR) agonist-based cancer immunotherapy.See details»
Decoy Biosystems Company Profile 2024: Valuation, Investors
Decoy Biosystems General Information Description. Developer of an immunotherapy platform intended to eliminate viral and bacterial infections in patients. The company's platform โฆSee details»
Decoy Biosystems, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Decoy Biosystems, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Decoy Biosystems, Inc. in San Diego, CA - (858) 492-0485 - Profile
Decoy Biosystems, Inc. is in the Biotechnical Research, Commercial business. View competitors, revenue, employees, website and phone number.See details»
Decoy Biosystems - Products, Competitors, Financials, Employees ...
Decoy Biosystems. Frequently Asked Questions (FAQ). When was Decoy Biosystems founded? Decoy Biosystems was founded in 2013. Where is Decoy Biosystems's headquarters? Decoy โฆSee details»
Decoy Biosystems Inc - Company Profile and News
Company profile page for Decoy Biosystems Inc including stock price, company news, executives, board members, and contact informationSee details»
Decoy Biosystems - VentureRadar
Website: https://www.decoybio.com/ Develops novel, potentially best-in-class cancer immunotherapy targeting multiple Toll-like receptors (TLR) to treat metastatic ...See details»
Decoy Biosystems - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Oct 23, 2018: Seed Round - โฆSee details»
Decoy Biosystems, Inc. - discovery-patsnap-com.libproxy.mit.edu
Https://www.decoybio.com. Decoy Biosystems, Inc. is a company that provides Substance abuse, Cancer immunology, Biotechnology and more. Decoy Biosystems, Inc. is headquartered in โฆSee details»
Decoy Biosystems, Inc. - Drug pipelines, Patents, Clinical trials
Explore Decoy Biosystems, Inc. with its drug pipeline, therapeutic area, technology platform, 2 news.See details»
Decoy Biosystems - Company Profile - Tracxn
Mar 17, 2024 Decoy Biosystems - Developer of small molecule-based immunotherapeutic solutions for the treatment of cancer. Raised a total funding of $6M over 1 round from 1 โฆSee details»
Decoy Biosystems - Contacts, Employees, Board Members
Decoy Biosystems is a biotechnology company developing novel, multi-targeted products designed to eliminate viral and bacterial infections.See details»
Decoy Therapeutics Inc. - Org Chart, Teams, Culture & Jobs - The โฆ
View Decoy Therapeutics Inc.'s up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Decoy - Company Profile - Tracxn
Nov 27, 2024 Decoy - Developer of therapeutics for infectious diseases. Founded by Bradley Pentelute in the year 2020. Decoy has 139 competitors.See details»
Decoy Biosystems - CB Insights
See Decoy Biosystems funding rounds, investors, investments, exits and more. Evaluate their financials based on Decoy Biosystems's post-money valuation and revenue.See details»
Decoy Biosystems - CB Insights
Explore {Decoy Biosystems's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Decoy Biosystems - Tech Stack, Apps, Patents & Trademarks
Decoy Biosystems is a biotechnology company developing novel, multi-targeted products designed to eliminate viral and bacterial infections.See details»
Decoy Smart Control - Org Chart, Teams, Culture & Jobs - The Org
View Decoy Smart Control's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Decoy - VentureRadar
Decoy is a Brazilian biotechnology startup dedicated to the research and development of pest control technologies for animals. They specialize in... ... Find out more ...See details»
Decoy scores $2m to bring biocontrols to animal ag: AFN Exclusive
Apr 28, 2022 When it comes to crops, biologicals are all the rage.Could livestock be next? Brazilโs Decoy Smart Control certainly thinks so. The Ribeirão Preto, São Paulo-based startup โฆSee details»